Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2025-01-13 00:00:00 ET · period of report 2025-01-09 · accession 0001334549-25-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-13 | 2025-01-09 | LSTA | Mazzo David J | Pres, CEO, Dir | A - Grant | $0.00 | +81.0K | 295.2K | +38% | $0 |
| DM | 2025-01-13 | 2025-01-09+ | LSTA | Mazzo David J | Pres, CEO, Dir | F - Tax | $3.79 | -30.5K | 285.7K | -10% | -$115.5K |
| D | 2025-01-13 | 2025-01-09 | LSTA | Mazzo David J | Pres, CEO, Dir | A - Grant | $0.00 | +40.0K | 40.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-09 | A | A | 81,000 | $0.00 | 295,152 | D | — | — | (F1) Represents 81,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. (F2) Includes 129,433 unvested restricted stock. |
| 2 | Common | Common Stock | 2025-01-10 | F | D | 3,106 | $3.73 | 264,690 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F4) Includes 122,750 unvested restricted stock. |
| 3 | Common | Common Stock | 2025-01-09 | F | D | 7,017 | $3.80 | 267,796 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 129,433 unvested restricted stock. |
| 4 | Common | Common Stock | 2025-01-09 | F | D | 10,925 | $3.80 | 274,813 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 129,433 unvested restricted stock. |
| 5 | Common | Common Stock | 2025-01-09 | F | D | 9,414 | $3.80 | 285,738 | D | — | — | (F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 129,433 unvested restricted stock. |
| 6 | Derivative | Stock Option (Right to Buy) | 2025-01-09 | A | A | 40,000 | $0.00 | 40,000 | D | $3.80 · 2025-01-09 to 2035-01-09 | 40,000 Common Stock | (F5) One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. |